CLASS II ONGOING Device recall · Reported 26 Nov 2025 · FDA Enforcement Report

Vacuette CAT Serum Separator Clot Activator recalled

Greiner Bio-One North America is recalling Vacuette CAT Serum Separator Clot Activator, distributed in 28 states. The recall was initiated on 19 Aug 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: Lot/Serial Numbers: Item# 455071P Lot# B250437N UDI-DI code: 29120017573061
Quantity recalled1,980,000

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0571-2026
FDA event ID
97499
Recalling firm
Greiner Bio-One North America, Monroe, NC
Classification
Class II
Status
Ongoing
Recall initiated
19 Aug 2025
FDA classified
19 Nov 2025
Reported
26 Nov 2025
Type
Voluntary: Firm initiated
Reason category
Potency & Assay

Timeline

19 Aug 2025Recall initiated by company
19 Nov 2025Classified by FDA+92 days
26 Nov 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Some of the Vacuette¿ CAT Serum Separator Clot Activator tubes were manufactured without gel separator, which could yield erroneous assay results and require the patient to return to the lab for recollection or repeat testing. This may result in delayed diagnosis, cause a delay in clinical decision-making or treatment and in some rare cases, yield incorrect results from less stable parameters.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Brand Name: Vacuette Product Name: 8 ml CAT Serum Separator Clot Activator Model/Catalog Number: 455071P Product Description: Greiner VACUETTE Blood Collection Tube with Clot Activator and Gel Separator and Standard Stopper (16 x 100 mm, 8ml)

Where it was distributed

U.S.: AL, AR, CA, CO, CT, FL, GA, IA, IL, IN, KS, LA, MA, MD, ME, MI, MO, MS, NJ, NY, OH, OK, PA, TN, TX, UT, VA and WY. O.U.S.: None

AlabamaArkansasCaliforniaColoradoConnecticutFloridaGeorgiaIowaIllinoisIndianaKansasLouisianaMassachusettsMarylandMaineMichiganMissouriMississippiNew JerseyNew York

Questions about this recall

Why was it recalled?

Some of the Vacuette¿ CAT Serum Separator Clot Activator tubes were manufactured without gel separator, which could yield erroneous assay results and require the patient to return to the lab for recollection or repeat testing. This may result in delayed diagnosis, cause a delay in clinical decision-making or treatment and in some rare cases, yield incorrect results from less stable parameters.

Which lots are affected?

Lot Code: Lot/Serial Numbers: Item# 455071P Lot# B250437N UDI-DI code: 29120017573061

Where was it sold?

U.S.: AL, AR, CA, CO, CT, FL, GA, IA, IL, IN, KS, LA, MA, MD, ME, MI, MO, MS, NJ, NY, OH, OK, PA, TN, TX, UT, VA and WY. O.U.S.: None

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Greiner Bio-One North America

All 16

Other Syringes & Needles recalls

All 1,066